ICODE: the international COVID-19 thrombosis biomarkers colloquium-novel soluble biomarkers: circulating cell-free nucleic acids and other molecules.

Krauel, Krystin; Duerschmied, Daniel

Krauel, Krystin; Duerschmied, Daniel.

Krauel K; Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany. krystin.krauel@universitaets-herzzentrum.de.
Duerschmied D; Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany.

J Thromb Thrombolysis ; 53(1): 83-87, 2022 Jan.

Article in English | MEDLINE | ID: covidwho-1226234

ABSTRACT

ABSTRACT

This article summarizes the evidence derived from clinical (observational) studies describing novel soluble biomarkers in COVID-19. Our goal was to stimulate further research (preclinical as well as clinical studies) and therefore we discuss potential prognostic value, but also technical details, such as sample preparation. A table provides an overview of the described biomarkers measured in plasma, serum or other (namely bronchoalveolar) fluids.

Subject(s)

COVID-19; Cell-Free Nucleic Acids; Thrombosis; Biomarkers/blood; COVID-19/diagnosis; Cell-Free Nucleic Acids/blood; Humans; Observational Studies as Topic; Thrombosis/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Cell-Free Nucleic Acids / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: J Thromb Thrombolysis Journal subject: Vascular Diseases Year: 2022 Document Type: Article Affiliation country: S11239-021-02468-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google